TY - JOUR T1 - Assembly 13: placing the pulmonary circulation in the heart of ERS JF - Breathe JO - Breathe SP - 88 LP - 89 DO - 10.1183/20734735.0349-2018 VL - 15 IS - 1 AU - Anton Vonk Noordegraaf AU - Marion Delcroix AU - David Jiminez AU - Oliver Sitbon AU - Harm Jan Bogaard Y1 - 2019/03/01 UR - http://breathe.ersjournals.com/content/15/1/88.abstract N2 - In 1988, Henri Denolin stated that the “pulmonary circulation is a kind of no-man's land between pulmonology and cardiology for everyone except physiologists”. In the years thereafter, the pulmonary field took over from the physiologist, expanding both our knowledge on the pulmonary circulation and the pathobiology of the different diseases affecting the pulmonary circulation. Novel clinical diagnostic tools made it possible to identify abnormal pulmonary circulatory conditions in a noninvasive way. Results from many studies showed that the pulmonary circulation is affected in almost all the currently known respiratory diseases and that the presence of pulmonary hypertension in any respiratory disease is associated with a poor outcome. The cause of death is inevitably the failing right ventricle. In addition, we came to recognise that pulmonary embolism and pulmonary arterial hypertension are far more frequent than had been assumed in the old days. The formation of centres of expertise in Europe was the next step leading to success. Scientific breakthroughs in these centres of expertise paved the way for the development of successful novel treatment. 30 years after the statement of Henri Denolin the European Respiratory Society (ERS) decided to create Assembly 13, entirely devoted to the pulmonary circulation, acknowledging the importance of the pulmonary circulation in respiratory diseases and the progress made in the field.Meet @ERStalk Assembly 13: pulmonary vascular diseases http://ow.ly/9t2430n2MhU ER -